InVivo Therapeutics Overview

  • Founded
  • 2005
Founded
  • Status
  • Public
  • Employees
  • 6
Employees
  • Stock Symbol
  • NVIV
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $1.14
  • (As of Wednesday Closing)

InVivo Therapeutics General Information

Description

InVivo Therapeutics Holdings Corp is a research and clinical stage biomaterials and biotechnology company. It focuses on the treatment of spinal cord injury. The company's product pipeline consists of Neuro spinal scaffold and Bioengineered neural trails. The firm has a clinical development program for acute spinal cord injury and a preclinical development program for chronic spinal cord injury.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Biotechnology
Stock Exchange
NAS
Primary Office
  • One Kendall Square
  • Building 1400 East, Floor 4
  • Cambridge, MA 02139
  • United States
+1 (617) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

InVivo Therapeutics Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.14 $1.26 $1.04 - $16.20 $5.56M 4.88M 162K -$18.38

InVivo Therapeutics Financials Summary

In Thousands,
USD
TTM 30-Jun-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV (265) (3,038) (5,439) 10,152
Revenue 0 0 0 0
EBITDA (10,732) (11,762) (23,538) (26,465)
Net Income (10,654) (11,830) (23,423) (26,745)
Total Assets 12,742 9,325 18,377 14,045
Total Debt 1,171 1,314 100 852
Public Fundamental Data provided by Morningstar, Inc. disclaimer

InVivo Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore InVivo Therapeutics‘s full profile, request access.

Request a free trial

InVivo Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
InVivo Therapeutics Holdings Corp is a research and clinical stage biomaterials and biotechnology company. It focuses on
Therapeutic Devices
Cambridge, MA
6 As of 2019
0000
00000000 0000

00000000

in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat no
0000 000000000
Clarksville, MD
0 As of 0000
00.000
0000000000 00.000

00000000

dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui o
00000000 0000000
Clarksville, TN
00 As of 0000
000.00
00 000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

InVivo Therapeutics Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NeuroNascent Venture Capital-Backed Clarksville, MD 0 00.000 0000000000 00.000
000000000 0000000 Private Equity-Backed Clarksville, TN 00 000.00 00 000000
00000 000000000000 Venture Capital-Backed Lausanne, Switzerland 00 000.00 00000000000 000.00
00000000 Angel-Backed New York, NY 0 00000 0000000000 0 00000
To view InVivo Therapeutics’s complete competitors history, request access »

InVivo Therapeutics Executive Team (13)

Name Title Board Seat Contact Info
Richard Toselli MD Chief Executive Officer & Board Member
Richard Christopher Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Tamara Joseph JD Senior Vice President, General Counsel & Chief Compliance Officer
Joseph Vacanti MD Co-Founder
Jay Blackington Vice President, Human Resources
You’re viewing 5 of 13 executive team members. Get the full list »

InVivo Therapeutics Board Members (5)

Name Representing Role Since
C. Merrifield Self Chairman & Board Member 000 0000
Christina Morrison Self Board Member 000 0000
Daniel Marshak Ph.D Self Board Member 000 0000
Richard Toselli MD InVivo Therapeutics Chief Executive Officer & Board Member 000 0000
To view InVivo Therapeutics’s complete board members history, request access »

InVivo Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

InVivo Therapeutics Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 00000000000 27-Oct-2010 000000000000000000 00.00 Surgical Devices 000000 000000 00.0
To view InVivo Therapeutics’s complete acquisitions history, request access »